This inventor holds 7 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Autotac Inc., Seoul National University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 8 
2 out of 1,784 
Years Active: 2023-2026
Title: The Innovative Contributions of Chang Hoon Ji
Introduction
Chang Hoon Ji is a prominent inventor based in Seoul, South Korea. With a remarkable portfolio of three patents, he has made significant strides in the field of pharmaceutical innovations. His work primarily revolves around novel compounds and compositions designed to effectively target and degrade specific proteins, contributing to advancements in disease treatment.
Latest Patents
Chang Hoon Ji's latest patents showcase his pioneering research in chimeric compounds and targeted protein degradation. One notable invention is the AUTOTAC chimeric compound, which incorporates a new p62 ligand connected to a target-binding ligand by a linker. This innovative compound offers potential therapeutic applications by selectively eliminating specific proteins, thereby preventing or treating various diseases. The second patent introduces a novel p62 ligand compound designed for the prevention and treatment of proteinopathies by activating autophagy in cells, which facilitates the elimination of unwanted proteins and aggregates.
Career Highlights
Throughout his career, Chang Hoon Ji has been associated with reputable organizations such as Autotac Inc. and the Seoul National University R&D Foundation. His expertise and innovative mindset have propelled advancements in the life sciences, particularly in drug delivery and targeted protein modulation.
Collaborations
Chang Hoon Ji has collaborated with other notable professionals, including Yong Tae Kwon and Srinivasrao Ganipisetti. These collaborations highlight the synergy between experts in the field, enhancing the potential for breakthroughs in therapeutic applications.
Conclusion
Chang Hoon Ji continues to push the boundaries of innovation through his inventive contributions. His work in developing targeted therapeutics demonstrates the critical role of inventors in advancing medical science and improving health outcomes. As he works towards further innovations, his patents will undoubtedly play a significant role in shaping future treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile